Randall J. Lanham Esq., J.D.
Net Worth
Last updated:
What is Randall J. Lanham Esq., J.D. net worth?
The estimated net worth of Mr. Randall J. Lanham Esq., J.D. is at least $2,273,390 as of 28 Oct 2018. He has received compensation worth at least $2,273,390 in Nymox Pharmaceutical Corporation.
What is the salary of Randall J. Lanham Esq., J.D.?
Mr. Randall J. Lanham Esq., J.D. salary is $324,770 per year as Gen. Counsel, Sec., Chief Operating Officer & Director in Nymox Pharmaceutical Corporation.
How old is Randall J. Lanham Esq., J.D.?
Mr. Randall J. Lanham Esq., J.D. is 61 years old, born in 1964.
What stocks does Randall J. Lanham Esq., J.D. currently own?
As insider, Mr. Randall J. Lanham Esq., J.D. owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Nymox Pharmaceutical Corporation (NYMX) | Gen. Counsel, Sec., Chief Operating Officer & Director | 152,900 | $0 | $0 |
What does Nymox Pharmaceutical Corporation do?
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperplasia, and Phase II clinical trials for low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. The company also develops and markets NicAlert and TobacAlert tests that use urine or saliva to detect use of tobacco products. In addition, it offers AlzheimAlert, a proprietary urine assay that aids physicians in the diagnosis of Alzheimer's disease, as well as researches and develops drug treatments for Alzheimer's disease. The company was founded in 1989 and is headquartered in Nassau, the Bahamas.
Randall J. Lanham Esq., J.D. insider trading
Nymox Pharmaceutical key executives
Nymox Pharmaceutical Corporation executives and other stock owners filed with the SEC:
- Mr. Erik Danielsen (62) Chief Financial Officer & Controller
- Mr. Randall J. Lanham Esq., J.D. (61) Gen. Counsel, Sec., Chief Operating Officer & Director